Literature DB >> 12614334

Estrogen activates protein kinase C in neurons: role in neuroprotection.

Myriam Cordey1, Usha Gundimeda, Rayudu Gopalakrishna, Christian J Pike.   

Abstract

It has been previously demonstrated that estrogen can protect neurons from a variety of insults, including beta-amyloid (Abeta). Recent studies have shown that estrogen can rapidly modulate intracellular signaling pathways involved in cell survival. In particular, estrogen activates protein kinase C (PKC) in a variety of cell types. This enzyme plays a key role in many cellular events, including regulation of apoptosis. In this study, we show that 17beta-estradiol (E2) rapidly increases PKC activity in primary cultures of rat cerebrocortical neurons. A 1 h pre-treatment with E2 or phorbol-12-myristate-13-acetate (PMA), a potent activator of PKC, protects neurons against Abeta toxicity. Protection afforded by both PMA and E2 is blocked by pharmacological inhibitors of PKC. Further, depletion of PKC levels resulting from prolonged PMA exposure prevents subsequent E2 or PMA protection. Our results indicate that E2 activates PKC in neurons, and that PKC activation is an important step in estrogen protection against Abeta. These data provide new understanding into the mechanism(s) underlying estrogen neuroprotection, an action with therapeutic relevance to Alzheimer's disease and other age-related neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614334     DOI: 10.1046/j.1471-4159.2003.01631.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

Review 1.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 2.  Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

Authors:  John H Morrison; Roberta D Brinton; Peter J Schmidt; Andrea C Gore
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

3.  17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.

Authors:  Hai-Rong Shi; Ling-Qiang Zhu; Shao-Hui Wang; Xin-An Liu; Qing Tian; Qi Zhang; Qun Wang; Jian-Zhi Wang
Journal:  J Neural Transm (Vienna)       Date:  2008-01-24       Impact factor: 3.575

Review 4.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 5.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

6.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

Review 7.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

8.  Ovariectomy increases neuronal amyloid-beta binding alcohol dehydrogenase level in the mouse hippocampus.

Authors:  Emiko Fukuzaki; Kazuhiro Takuma; Yoko Funatsu; Yukiko Himeno; Yuko Kitahara; Bin Gu; Hiroyuki Mizoguchi; Daisuke Ibi; Koji Koike; Masaki Inoue; Shi Du Yan; Kiyofumi Yamada
Journal:  Neurochem Int       Date:  2008-03-10       Impact factor: 3.921

Review 9.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

10.  Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and β-amyloid pathology.

Authors:  Eva Alonso; Carmen Vale; Mercedes R Vieytes; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2013-04-08       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.